Alex Goraltchouk

Company: Remedium Bio

Job title: Chief Operating Officer

Bio:

Alex is an Operations, Engineering, and R&D executive having held roles of increasing responsibility at companies ranging from start-up to Fortune 500 including Allergan, Biogen, and Regeneron. He holds a Bachelor in Materials and Master in Chemical Engineering, MBA and Master of Science in Finance, as well as a Master in Microbiology and Cell Sciences.

Seminars:

A 101 in Biotech Financial Risk Management 2:05 pm

How to demonstrate value proposition and attract investment as a biotech with a novel vector platform ‘Build vs Buy’: weighing up whether to develop or license functionalities Identifying healthy business development opportunities Diversifying risk across a portfolioRead more

day: PRE-CONFERENCE WORKSHOP DAY

Prometheus: The First Adjustable Dose Gene Therapy Platform Technology 11:00 am

An engineered gene therapy by design: ultra-low-cost, non-antigenic, specific, localized, and exceptionally well tolerated Overcoming the challenges of gene therapy’s fixed dose nature via a novel dose adjustment mechanism Enabling the replacement of subcutaneous protein treatments, with zero-order kinetics deliveryRead more

day: Conference Day Two